Cooper Companies' Q1 Earnings Surpass Expectations, Lifts FY22 Outlook
- Oops!Something went wrong.Please try again later.
- COO
See more from Benzinga
Evolus Reports Narrower Q4 Loss, CFO Retires, Reaffirms FY22 Outlook
Eli Lilly's JAK Inhibitor Baricitinib Cuts Death Risk By 13% In COVID-19 Patients
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.